gadolinium has been researched along with Hemophilia A in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berntorp, E; Jonsson, K; Ljung, R; Lundin, B; Pettersson, H; Ståhlberg, F; Wirestam, R | 1 |
Eickhoff, H; Hamann, M; Koch, W; Kunze, V; Nägele, M; Oldenburg, J; Reiser, M; Steudel, A | 1 |
2 other study(ies) available for gadolinium and Hemophilia A
Article | Year |
---|---|
Gadolinium contrast agent is of limited value for magnetic resonance imaging assessment of synovial hypertrophy in hemophiliacs.
Topics: Adult; Contrast Media; Gadolinium; Hemophilia A; Heterocyclic Compounds; Humans; Hypertrophy; Knee Joint; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Radiography; Synovial Membrane | 2007 |
[Hemophiliac arthropathy of the knee joint. Gd-DTPA-enhanced MRI; clinical and roentgenological correlation].
Topics: Adult; Contrast Media; Gadolinium; Gadolinium DTPA; Hemarthrosis; Hemophilia A; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Radiography; Synovial Membrane | 1994 |